次新基业绩首尾相差逾46个百分点，建仓节奏成胜负手

Group 1 - The A-share market has shown resilience in the second quarter, with the Shanghai Composite Index rebounding 9.2% from its low of 3040.69 points on April 7 to 3381.58 points by June 23 [1] - There is significant performance differentiation among newly established funds, with a gap exceeding 46 percentage points due to varying investment strategies and timing of market entry [2][3] - The healthcare sector, particularly innovative drugs, has been a key driver of fund performance, with some funds achieving returns over 20% despite market volatility [3] Group 2 - The second quarter has seen a notable increase in the issuance of equity funds, with over half of the 247 newly established products raising funds in less than 15 days, indicating a rush to capitalize on market opportunities [5] - The market is currently characterized by both opportunities and risks, with sectors like AI, humanoid robots, and innovative drugs showing high local interest, although some companies may still face valuation challenges [6][8] - The overall valuation of the A-share market remains historically low, supported by a dual easing monetary and fiscal policy environment, while uncertainties from global trade tensions pose risks [8]